Literature DB >> 18762572

Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma.

A Russell-Swetek1, A N West, J E Mintern, J Jenkins, C Rodriguez-Galindo, R Ribeiro, G P Zambetti.   

Abstract

Paediatric choroid plexus carcinomas (CPC) and adrenocortical carcinomas (ACC) are exceedingly rare tumours, each occurring at an annual rate of 0.3 cases per million children or less. Although both tumour types are associated with Li-Fraumeni syndrome (LFS), the penetrance of germline TP53 mutations in CPC remains to be established. We report here a young boy without a family history of cancer who presented with CPC and subsequently ACC. Genetic testing revealed a novel de novo germline TP53 mutation (E285V). Neither tumour underwent loss of heterozygosity. Consistent with this observation, functional analyses demonstrated that E285V acts as a dominant negative mutant that is defective in regulating target gene expression, growth suppression and apoptosis. These results further strengthen the association between germline TP53 mutations and childhood CPC, even when occurring in the absence of familial tumour susceptibility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762572      PMCID: PMC3487594          DOI: 10.1136/jmg.2008.059568

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  16 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 2.  The p53 mutation "gradient effect" and its clinical implications.

Authors:  Gerard P Zambetti
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

3.  An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.

Authors:  R C Ribeiro; F Sandrini; B Figueiredo; G P Zambetti; E Michalkiewicz; A R Lafferty; L DeLacerda; M Rabin; C Cadwell; G Sampaio; I Cat; C A Stratakis; R Sandrini
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

4.  Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma.

Authors:  Alina Nico West; Raul C Ribeiro; Jesse Jenkins; Carlos Rodriguez-Galindo; Bonald C Figueiredo; Richard Kriwacki; Gerard P Zambetti
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

5.  Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.

Authors:  J M Varley; G McGown; M Thorncroft; L A James; G P Margison; G Forster; D G Evans; M Harris; A M Kelsey; J M Birch
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

6.  Two cases of osteosarcoma occurring as second malignancy of childhood cancer.

Authors:  T Yonemoto; S Tatezaki; T Ishii; T Satoh; M Inoue
Journal:  Anticancer Res       Date:  1999 Nov-Dec       Impact factor: 2.480

7.  Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.

Authors:  Audrey Petitjean; Ewy Mathe; Shunsuke Kato; Chikashi Ishioka; Sean V Tavtigian; Pierre Hainaut; Magali Olivier
Journal:  Hum Mutat       Date:  2007-06       Impact factor: 4.878

Review 8.  Biology, clinical characteristics, and management of adrenocortical tumors in children.

Authors:  Carlos Rodriguez-Galindo; Bonald C Figueiredo; Gerard P Zambetti; Raul C Ribeiro
Journal:  Pediatr Blood Cancer       Date:  2005-09       Impact factor: 3.167

Review 9.  The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth.

Authors:  C Cadwell; G P Zambetti
Journal:  Gene       Date:  2001-10-17       Impact factor: 3.688

10.  Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations.

Authors:  A Vital; P P Bringuier; H Huang; F San Galli; J Rivel; S Ansoborlo; J M Cazauran; L Taillandier; P Kleihues; H Ohgaki
Journal:  J Neuropathol Exp Neurol       Date:  1998-11       Impact factor: 3.685

View more
  9 in total

1.  Reply to: Familial syndromes associated with intracranial tumours: a review.

Authors:  Fonnet E Bleeker
Journal:  Childs Nerv Syst       Date:  2015-08-09       Impact factor: 1.475

2.  Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.

Authors:  Jonathan D Wasserman; Ana Novokmet; Claudia Eichler-Jonsson; Raul C Ribeiro; Carlos Rodriguez-Galindo; Gerard P Zambetti; David Malkin
Journal:  J Clin Oncol       Date:  2015-01-12       Impact factor: 44.544

3.  TP53-Associated Pediatric Malignancies.

Authors:  Emilia M Pinto; Raul C Ribeiro; Bonald C Figueiredo; Gerard P Zambetti
Journal:  Genes Cancer       Date:  2011-04

4.  Virilizing adrenocortical carcinoma in a child with Turner syndrome and somatic TP53 gene mutation.

Authors:  Jung-Hee Ko; Hyo Sung Lee; Jeong Hong; Jin Soon Hwang
Journal:  Eur J Pediatr       Date:  2009-08-25       Impact factor: 3.183

5.  Coincident choroid plexus carcinoma and adrenocortical tumor in an infant.

Authors:  Kazuhiko Yoshida; Kazufumi Sato; Ryuhei Kitai; Norichika Hashimoto; Toshihiko Kubota; Ken-Ichiro Kikuta
Journal:  Brain Tumor Pathol       Date:  2012-07-01       Impact factor: 3.298

6.  A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma.

Authors:  Sheng-Qing Lv; Ye-Chun Song; Jian-Ping Xu; Hai-Feng Shu; Zheng Zhou; Ning An; Qi-Lin Huang; Hui Yang
Journal:  Med Sci Monit       Date:  2012-05

7.  Vulnerability of drug-resistant EML4-ALK rearranged lung cancer to transcriptional inhibition.

Authors:  Athanasios R Paliouras; Marta Buzzetti; Lei Shi; Ian J Donaldson; Peter Magee; Sudhakar Sahoo; Hui-Sun Leong; Matteo Fassan; Matthew Carter; Gianpiero Di Leva; Matthew G Krebs; Fiona Blackhall; Christine M Lovly; Michela Garofalo
Journal:  EMBO Mol Med       Date:  2020-06-17       Impact factor: 12.137

8.  Genetic and histopathological analysis of a case of primary intraosseous carcinoma, NOS with features of both ameloblastic carcinoma and squamous cell carcinoma.

Authors:  Akane Yukimori; Maiko Tsuchiya; Akane Wada; Yasuyuki Michi; Kou Kayamori; Kei Sakamoto; Tohru Ikeda
Journal:  World J Surg Oncol       Date:  2020-02-29       Impact factor: 2.754

Review 9.  What 20 years of research has taught us about the TP53 p.R337H mutation.

Authors:  Emilia Modolo Pinto; Gerard P Zambetti
Journal:  Cancer       Date:  2020-08-17       Impact factor: 6.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.